Niagen Bioscience, Inc. - Common Stock (NAGE)

Historical Holders from Q1 2016 to Q3 2025

Symbol
NAGE on Nasdaq
CUSIP
171077407
Type / Class
Equity / Common Stock
Shares outstanding
79.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
31.7M
Holdings value
$296M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
159
Number of buys
98
Number of sells
-61
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Niagen Bioscience, Inc. - Common Stock (NAGE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 5.04% $37.5M 4.02M The Vanguard Group Sep 30, 2025

Institutional Holders of Niagen Bioscience, Inc. - Common Stock (NAGE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 31.7M $296M +$18.2M $9.33 159
2025 Q2 29M $418M +$66.4M $14.41 153
2025 Q1 24.9M $172M +$17.9M $6.90 138
2024 Q4 22.5M $119M +$25.3M $5.31 121
2024 Q3 17.6M $64.3M +$3.09M $3.65 90
2024 Q2 16.5M $45.1M +$8.63M $2.73 78
2024 Q1 13.1M $45.7M +$5.88M $3.48 65
2023 Q4 11.6M $16.5M +$387K $1.43 52
2023 Q3 11.2M $16.4M +$44.2K $1.46 53
2023 Q2 11.2M $17.7M -$923K $1.57 54
2023 Q1 11.8M $18.1M +$689K $1.53 56
2022 Q4 11.4M $19.1M -$441K $1.68 56
2022 Q3 12.2M $15M -$3.81M $1.23 56
2022 Q2 15.2M $25.3M -$9.38M $1.67 67
2022 Q1 20.3M $49.9M -$626K $2.46 80
2021 Q4 20.2M $75.9M -$3.74M $3.74 78
2021 Q3 20.5M $129M -$1.07M $6.27 83
2021 Q2 20.4M $201M -$22.2M $9.86 98
2021 Q1 22.6M $211M +$69.4M $9.34 94
2020 Q4 15.9M $76.1M +$2.86M $4.80 81
2020 Q3 15.3M $61.3M +$4.47M $4.01 73
2020 Q2 14.1M $64.9M +$6.48M $4.59 64
2020 Q1 12.8M $41.6M +$1.19M $3.26 59
2019 Q4 12.7M $54.7M +$1.96M $4.31 64
2019 Q3 11.6M $45.6M +$2.34M $3.94 59
2019 Q2 11M $51.2M +$4.98M $4.65 58
2019 Q1 10.1M $42.2M +$2.23M $4.19 59
2018 Q4 9.54M $32.7M -$394K $3.43 57
2018 Q3 9.54M $40.9M +$2.59M $4.29 64
2018 Q2 8.94M $33.2M +$8.1M $3.71 64
2018 Q1 6.6M $27.7M +$3.13M $4.20 57
2017 Q4 5.63M $33.1M +$14M $5.88 52
2017 Q3 3.29M $14.2M -$2.11M $4.30 40
2017 Q2 3.85M $14.7M -$3.74M $3.82 44
2017 Q1 5.05M $13.6M +$4.34M $2.69 45
2016 Q4 4.61M $15.3M +$829K $3.31 52
2016 Q3 4.38M $13M +$973K $2.98 48
2016 Q2 3.98M $16.5M +$16.5M $4.14 46
2016 Q1 10K $14K +$14K $1.40 1